What is the projected market valuation of the Thoracic Surgery Market by 2035?

The Thoracic Surgery Market is projected to reach a valuation of 30.55 USD Billion by 2035. Read More

What was the market valuation of the Thoracic Surgery Market in 2024?

In 2024, the overall market valuation was 18.01 USD Billion. Read More

What is the expected CAGR for the Thoracic Surgery Market during the forecast period 2025 - 2035?

The expected CAGR for the Thoracic Surgery Market during the forecast period 2025 - 2035 is 4.92%. Read More

Which companies are considered key players in the Thoracic Surgery Market?

Key players in the Thoracic Surgery Market include Medtronic, Johnson & Johnson, Boston Scientific, and Stryker. Read More

What are the projected revenues for Open Thoracic Surgery by 2035?

The projected revenues for Open Thoracic Surgery are expected to reach 9.0 USD Billion by 2035. Read More

How does the revenue for Video-Assisted Thoracoscopic Surgery (VATS) compare to other procedures by 2035?

By 2035, Video-Assisted Thoracoscopic Surgery (VATS) is projected to generate revenues of 12.0 USD Billion, indicating strong growth. Read More

What is the expected revenue for lung cancer treatments in the Thoracic Surgery Market by 2035?

The expected revenue for lung cancer treatments in the Thoracic Surgery Market is projected to be 12.0 USD Billion by 2035. Read More

What segment of the Thoracic Surgery Market is anticipated to have the highest revenue growth?

The Therapeutic segment is anticipated to have the highest revenue growth, projected to reach 17.0 USD Billion by 2035. Read More

What is the revenue projection for inpatient thoracic surgeries by 2035?

Inpatient thoracic surgeries are projected to generate revenues of 17.0 USD Billion by 2035. Read More

What surgical approach is expected to see significant growth in the Thoracic Surgery Market?

The Minimally Invasive Approach is expected to see significant growth, with projected revenues of 13.55 USD Billion by 2035. Read More

Thoracic Surgery Market

ID: MRFR/HC/26215-HCR

100 Pages

Rahul Gotadki

Last Updated: April 06, 2026

Thoracic Surgery Market Research Report By Procedure Type (Open Thoracic Surgery, Video-Assisted Thoracoscopic Surgery (VATS), Robotics-Assisted Thoracic Surgery (RATS)), By Medical Condition (Lung Cancer, Esophageal Cancer, Mediastinal Tumors, Pneumothorax, Empyema), By Patient Type (Inpatients, Outpatients), By Surgical Approach (Standard Approach, Minimally Invasive Approach), By Surgical Scope (Diagnostic, Therapeutic, Emergency) and By Regional (North America, Europe, South America, Asia Pacific, Middle East and Africa) - Growth & Industry Forecast 2025 To 2035

Summary Table of Contents Segmentation Download PDF

1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
1.1 EXECUTIVE SUMMARY
1.1.1 Market Overview
1.1.2 Key Findings
1.1.3 Market Segmentation
1.1.4 Competitive Landscape
1.1.5 Challenges and Opportunities
1.1.6 Future Outlook
2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
2.1 MARKET INTRODUCTION
2.1.1 Definition
2.1.2 Scope of the study
2.1.2.1 Research Objective
2.1.2.2 Assumption
2.1.2.3 Limitations
2.2 RESEARCH METHODOLOGY
2.2.1 Overview
2.2.2 Data Mining
2.2.3 Secondary Research
2.2.4 Primary Research
2.2.4.1 Primary Interviews and Information Gathering Process
2.2.4.2 Breakdown of Primary Respondents
2.2.5 Forecasting Model
2.2.6 Market Size Estimation
2.2.6.1 Bottom-Up Approach
2.2.6.2 Top-Down Approach
2.2.7 Data Triangulation
2.2.8 Validation
3 SECTION III: QUALITATIVE ANALYSIS
3.1 MARKET DYNAMICS
3.1.1 Overview
3.1.2 Drivers
3.1.3 Restraints
3.1.4 Opportunities
3.2 MARKET FACTOR ANALYSIS
3.2.1 Value chain Analysis
3.2.2 Porter's Five Forces Analysis
3.2.2.1 Bargaining Power of Suppliers
3.2.2.2 Bargaining Power of Buyers
3.2.2.3 Threat of New Entrants
3.2.2.4 Threat of Substitutes
3.2.2.5 Intensity of Rivalry
3.2.3 COVID-19 Impact Analysis
3.2.3.1 Market Impact Analysis
3.2.3.2 Regional Impact
3.2.3.3 Opportunity and Threat Analysis
4 SECTION IV: QUANTITATIVE ANALYSIS
4.1 Healthcare, BY Procedure Type (USD Billion)
4.1.1 Open Thoracic Surgery
4.1.2 Video-Assisted Thoracoscopic Surgery (VATS)
4.1.3 Robotics-Assisted Thoracic Surgery (RATS)
4.2 Healthcare, BY Medical Condition (USD Billion)
4.2.1 Lung Cancer
4.2.2 Esophageal Cancer
4.2.3 Mediastinal Tumors
4.2.4 Pneumothorax
4.2.5 Empyema
4.3 Healthcare, BY Patient Type (USD Billion)
4.3.1 Inpatients
4.3.2 Outpatients
4.4 Healthcare, BY Surgical Approach (USD Billion)
4.4.1 Standard Approach
4.4.2 Minimally Invasive Approach
4.5 Healthcare, BY Surgical Scope (USD Billion)
4.5.1 Diagnostic
4.5.2 Therapeutic
4.5.3 Emergency
4.6 Healthcare, BY Region (USD Billion)
4.6.1 North America
4.6.1.1 US
4.6.1.2 Canada
4.6.2 Europe
4.6.2.1 Germany
4.6.2.2 UK
4.6.2.3 France
4.6.2.4 Russia
4.6.2.5 Italy
4.6.2.6 Spain
4.6.2.7 Rest of Europe
4.6.3 APAC
4.6.3.1 China
4.6.3.2 India
4.6.3.3 Japan
4.6.3.4 South Korea
4.6.3.5 Malaysia
4.6.3.6 Thailand
4.6.3.7 Indonesia
4.6.3.8 Rest of APAC
4.6.4 South America
4.6.4.1 Brazil
4.6.4.2 Mexico
4.6.4.3 Argentina
4.6.4.4 Rest of South America
4.6.5 MEA
4.6.5.1 GCC Countries
4.6.5.2 South Africa
4.6.5.3 Rest of MEA
5 SECTION V: COMPETITIVE ANALYSIS
5.1 Competitive Landscape
5.1.1 Overview
5.1.2 Competitive Analysis
5.1.3 Market share Analysis
5.1.4 Major Growth Strategy in the Healthcare
5.1.5 Competitive Benchmarking
5.1.6 Leading Players in Terms of Number of Developments in the Healthcare
5.1.7 Key developments and growth strategies
5.1.7.1 New Product Launch/Service Deployment
5.1.7.2 Merger & Acquisitions
5.1.7.3 Joint Ventures
5.1.8 Major Players Financial Matrix
5.1.8.1 Sales and Operating Income
5.1.8.2 Major Players R&D Expenditure. 2023
5.2 Company Profiles
5.2.1 Medtronic (US)
5.2.1.1 Financial Overview
5.2.1.2 Products Offered
5.2.1.3 Key Developments
5.2.1.4 SWOT Analysis
5.2.1.5 Key Strategies
5.2.2 Johnson & Johnson (US)
5.2.2.1 Financial Overview
5.2.2.2 Products Offered
5.2.2.3 Key Developments
5.2.2.4 SWOT Analysis
5.2.2.5 Key Strategies
5.2.3 Boston Scientific (US)
5.2.3.1 Financial Overview
5.2.3.2 Products Offered
5.2.3.3 Key Developments
5.2.3.4 SWOT Analysis
5.2.3.5 Key Strategies
5.2.4 Stryker (US)
5.2.4.1 Financial Overview
5.2.4.2 Products Offered
5.2.4.3 Key Developments
5.2.4.4 SWOT Analysis
5.2.4.5 Key Strategies
5.2.5 Abbott Laboratories (US)
5.2.5.1 Financial Overview
5.2.5.2 Products Offered
5.2.5.3 Key Developments
5.2.5.4 SWOT Analysis
5.2.5.5 Key Strategies
5.2.6 B. Braun Melsungen AG (DE)
5.2.6.1 Financial Overview
5.2.6.2 Products Offered
5.2.6.3 Key Developments
5.2.6.4 SWOT Analysis
5.2.6.5 Key Strategies
5.2.7 Smith & Nephew (GB)
5.2.7.1 Financial Overview
5.2.7.2 Products Offered
5.2.7.3 Key Developments
5.2.7.4 SWOT Analysis
5.2.7.5 Key Strategies
5.2.8 Terumo Corporation (JP)
5.2.8.1 Financial Overview
5.2.8.2 Products Offered
5.2.8.3 Key Developments
5.2.8.4 SWOT Analysis
5.2.8.5 Key Strategies
5.2.9 Intuitive Surgical (US)
5.2.9.1 Financial Overview
5.2.9.2 Products Offered
5.2.9.3 Key Developments
5.2.9.4 SWOT Analysis
5.2.9.5 Key Strategies
5.3 Appendix
5.3.1 References
5.3.2 Related Reports
6 LIST OF FIGURES
6.1 MARKET SYNOPSIS
6.2 NORTH AMERICA MARKET ANALYSIS
6.3 US MARKET ANALYSIS BY PROCEDURE TYPE
6.4 US MARKET ANALYSIS BY MEDICAL CONDITION
6.5 US MARKET ANALYSIS BY PATIENT TYPE
6.6 US MARKET ANALYSIS BY SURGICAL APPROACH
6.7 US MARKET ANALYSIS BY SURGICAL SCOPE
6.8 CANADA MARKET ANALYSIS BY PROCEDURE TYPE
6.9 CANADA MARKET ANALYSIS BY MEDICAL CONDITION
6.10 CANADA MARKET ANALYSIS BY PATIENT TYPE
6.11 CANADA MARKET ANALYSIS BY SURGICAL APPROACH
6.12 CANADA MARKET ANALYSIS BY SURGICAL SCOPE
6.13 EUROPE MARKET ANALYSIS
6.14 GERMANY MARKET ANALYSIS BY PROCEDURE TYPE
6.15 GERMANY MARKET ANALYSIS BY MEDICAL CONDITION
6.16 GERMANY MARKET ANALYSIS BY PATIENT TYPE
6.17 GERMANY MARKET ANALYSIS BY SURGICAL APPROACH
6.18 GERMANY MARKET ANALYSIS BY SURGICAL SCOPE
6.19 UK MARKET ANALYSIS BY PROCEDURE TYPE
6.20 UK MARKET ANALYSIS BY MEDICAL CONDITION
6.21 UK MARKET ANALYSIS BY PATIENT TYPE
6.22 UK MARKET ANALYSIS BY SURGICAL APPROACH
6.23 UK MARKET ANALYSIS BY SURGICAL SCOPE
6.24 FRANCE MARKET ANALYSIS BY PROCEDURE TYPE
6.25 FRANCE MARKET ANALYSIS BY MEDICAL CONDITION
6.26 FRANCE MARKET ANALYSIS BY PATIENT TYPE
6.27 FRANCE MARKET ANALYSIS BY SURGICAL APPROACH
6.28 FRANCE MARKET ANALYSIS BY SURGICAL SCOPE
6.29 RUSSIA MARKET ANALYSIS BY PROCEDURE TYPE
6.30 RUSSIA MARKET ANALYSIS BY MEDICAL CONDITION
6.31 RUSSIA MARKET ANALYSIS BY PATIENT TYPE
6.32 RUSSIA MARKET ANALYSIS BY SURGICAL APPROACH
6.33 RUSSIA MARKET ANALYSIS BY SURGICAL SCOPE
6.34 ITALY MARKET ANALYSIS BY PROCEDURE TYPE
6.35 ITALY MARKET ANALYSIS BY MEDICAL CONDITION
6.36 ITALY MARKET ANALYSIS BY PATIENT TYPE
6.37 ITALY MARKET ANALYSIS BY SURGICAL APPROACH
6.38 ITALY MARKET ANALYSIS BY SURGICAL SCOPE
6.39 SPAIN MARKET ANALYSIS BY PROCEDURE TYPE
6.40 SPAIN MARKET ANALYSIS BY MEDICAL CONDITION
6.41 SPAIN MARKET ANALYSIS BY PATIENT TYPE
6.42 SPAIN MARKET ANALYSIS BY SURGICAL APPROACH
6.43 SPAIN MARKET ANALYSIS BY SURGICAL SCOPE
6.44 REST OF EUROPE MARKET ANALYSIS BY PROCEDURE TYPE
6.45 REST OF EUROPE MARKET ANALYSIS BY MEDICAL CONDITION
6.46 REST OF EUROPE MARKET ANALYSIS BY PATIENT TYPE
6.47 REST OF EUROPE MARKET ANALYSIS BY SURGICAL APPROACH
6.48 REST OF EUROPE MARKET ANALYSIS BY SURGICAL SCOPE
6.49 APAC MARKET ANALYSIS
6.50 CHINA MARKET ANALYSIS BY PROCEDURE TYPE
6.51 CHINA MARKET ANALYSIS BY MEDICAL CONDITION
6.52 CHINA MARKET ANALYSIS BY PATIENT TYPE
6.53 CHINA MARKET ANALYSIS BY SURGICAL APPROACH
6.54 CHINA MARKET ANALYSIS BY SURGICAL SCOPE
6.55 INDIA MARKET ANALYSIS BY PROCEDURE TYPE
6.56 INDIA MARKET ANALYSIS BY MEDICAL CONDITION
6.57 INDIA MARKET ANALYSIS BY PATIENT TYPE
6.58 INDIA MARKET ANALYSIS BY SURGICAL APPROACH
6.59 INDIA MARKET ANALYSIS BY SURGICAL SCOPE
6.60 JAPAN MARKET ANALYSIS BY PROCEDURE TYPE
6.61 JAPAN MARKET ANALYSIS BY MEDICAL CONDITION
6.62 JAPAN MARKET ANALYSIS BY PATIENT TYPE
6.63 JAPAN MARKET ANALYSIS BY SURGICAL APPROACH
6.64 JAPAN MARKET ANALYSIS BY SURGICAL SCOPE
6.65 SOUTH KOREA MARKET ANALYSIS BY PROCEDURE TYPE
6.66 SOUTH KOREA MARKET ANALYSIS BY MEDICAL CONDITION
6.67 SOUTH KOREA MARKET ANALYSIS BY PATIENT TYPE
6.68 SOUTH KOREA MARKET ANALYSIS BY SURGICAL APPROACH
6.69 SOUTH KOREA MARKET ANALYSIS BY SURGICAL SCOPE
6.70 MALAYSIA MARKET ANALYSIS BY PROCEDURE TYPE
6.71 MALAYSIA MARKET ANALYSIS BY MEDICAL CONDITION
6.72 MALAYSIA MARKET ANALYSIS BY PATIENT TYPE
6.73 MALAYSIA MARKET ANALYSIS BY SURGICAL APPROACH
6.74 MALAYSIA MARKET ANALYSIS BY SURGICAL SCOPE
6.75 THAILAND MARKET ANALYSIS BY PROCEDURE TYPE
6.76 THAILAND MARKET ANALYSIS BY MEDICAL CONDITION
6.77 THAILAND MARKET ANALYSIS BY PATIENT TYPE
6.78 THAILAND MARKET ANALYSIS BY SURGICAL APPROACH
6.79 THAILAND MARKET ANALYSIS BY SURGICAL SCOPE
6.80 INDONESIA MARKET ANALYSIS BY PROCEDURE TYPE
6.81 INDONESIA MARKET ANALYSIS BY MEDICAL CONDITION
6.82 INDONESIA MARKET ANALYSIS BY PATIENT TYPE
6.83 INDONESIA MARKET ANALYSIS BY SURGICAL APPROACH
6.84 INDONESIA MARKET ANALYSIS BY SURGICAL SCOPE
6.85 REST OF APAC MARKET ANALYSIS BY PROCEDURE TYPE
6.86 REST OF APAC MARKET ANALYSIS BY MEDICAL CONDITION
6.87 REST OF APAC MARKET ANALYSIS BY PATIENT TYPE
6.88 REST OF APAC MARKET ANALYSIS BY SURGICAL APPROACH
6.89 REST OF APAC MARKET ANALYSIS BY SURGICAL SCOPE
6.90 SOUTH AMERICA MARKET ANALYSIS
6.91 BRAZIL MARKET ANALYSIS BY PROCEDURE TYPE
6.92 BRAZIL MARKET ANALYSIS BY MEDICAL CONDITION
6.93 BRAZIL MARKET ANALYSIS BY PATIENT TYPE
6.94 BRAZIL MARKET ANALYSIS BY SURGICAL APPROACH
6.95 BRAZIL MARKET ANALYSIS BY SURGICAL SCOPE
6.96 MEXICO MARKET ANALYSIS BY PROCEDURE TYPE
6.97 MEXICO MARKET ANALYSIS BY MEDICAL CONDITION
6.98 MEXICO MARKET ANALYSIS BY PATIENT TYPE
6.99 MEXICO MARKET ANALYSIS BY SURGICAL APPROACH
6.100 MEXICO MARKET ANALYSIS BY SURGICAL SCOPE
6.101 ARGENTINA MARKET ANALYSIS BY PROCEDURE TYPE
6.102 ARGENTINA MARKET ANALYSIS BY MEDICAL CONDITION
6.103 ARGENTINA MARKET ANALYSIS BY PATIENT TYPE
6.104 ARGENTINA MARKET ANALYSIS BY SURGICAL APPROACH
6.105 ARGENTINA MARKET ANALYSIS BY SURGICAL SCOPE
6.106 REST OF SOUTH AMERICA MARKET ANALYSIS BY PROCEDURE TYPE
6.107 REST OF SOUTH AMERICA MARKET ANALYSIS BY MEDICAL CONDITION
6.108 REST OF SOUTH AMERICA MARKET ANALYSIS BY PATIENT TYPE
6.109 REST OF SOUTH AMERICA MARKET ANALYSIS BY SURGICAL APPROACH
6.110 REST OF SOUTH AMERICA MARKET ANALYSIS BY SURGICAL SCOPE
6.111 MEA MARKET ANALYSIS
6.112 GCC COUNTRIES MARKET ANALYSIS BY PROCEDURE TYPE
6.113 GCC COUNTRIES MARKET ANALYSIS BY MEDICAL CONDITION
6.114 GCC COUNTRIES MARKET ANALYSIS BY PATIENT TYPE
6.115 GCC COUNTRIES MARKET ANALYSIS BY SURGICAL APPROACH
6.116 GCC COUNTRIES MARKET ANALYSIS BY SURGICAL SCOPE
6.117 SOUTH AFRICA MARKET ANALYSIS BY PROCEDURE TYPE
6.118 SOUTH AFRICA MARKET ANALYSIS BY MEDICAL CONDITION
6.119 SOUTH AFRICA MARKET ANALYSIS BY PATIENT TYPE
6.120 SOUTH AFRICA MARKET ANALYSIS BY SURGICAL APPROACH
6.121 SOUTH AFRICA MARKET ANALYSIS BY SURGICAL SCOPE
6.122 REST OF MEA MARKET ANALYSIS BY PROCEDURE TYPE
6.123 REST OF MEA MARKET ANALYSIS BY MEDICAL CONDITION
6.124 REST OF MEA MARKET ANALYSIS BY PATIENT TYPE
6.125 REST OF MEA MARKET ANALYSIS BY SURGICAL APPROACH
6.126 REST OF MEA MARKET ANALYSIS BY SURGICAL SCOPE
6.127 KEY BUYING CRITERIA OF HEALTHCARE
6.128 RESEARCH PROCESS OF MRFR
6.129 DRO ANALYSIS OF HEALTHCARE
6.130 DRIVERS IMPACT ANALYSIS: HEALTHCARE
6.131 RESTRAINTS IMPACT ANALYSIS: HEALTHCARE
6.132 SUPPLY / VALUE CHAIN: HEALTHCARE
6.133 HEALTHCARE, BY PROCEDURE TYPE, 2024 (% SHARE)
6.134 HEALTHCARE, BY PROCEDURE TYPE, 2024 TO 2035 (USD Billion)
6.135 HEALTHCARE, BY MEDICAL CONDITION, 2024 (% SHARE)
6.136 HEALTHCARE, BY MEDICAL CONDITION, 2024 TO 2035 (USD Billion)
6.137 HEALTHCARE, BY PATIENT TYPE, 2024 (% SHARE)
6.138 HEALTHCARE, BY PATIENT TYPE, 2024 TO 2035 (USD Billion)
6.139 HEALTHCARE, BY SURGICAL APPROACH, 2024 (% SHARE)
6.140 HEALTHCARE, BY SURGICAL APPROACH, 2024 TO 2035 (USD Billion)
6.141 HEALTHCARE, BY SURGICAL SCOPE, 2024 (% SHARE)
6.142 HEALTHCARE, BY SURGICAL SCOPE, 2024 TO 2035 (USD Billion)
6.143 BENCHMARKING OF MAJOR COMPETITORS
7 LIST OF TABLES
7.1 LIST OF ASSUMPTIONS
7.1.1
7.2 North America MARKET SIZE ESTIMATES; FORECAST
7.2.1 BY PROCEDURE TYPE, 2025-2035 (USD Billion)
7.2.2 BY MEDICAL CONDITION, 2025-2035 (USD Billion)
7.2.3 BY PATIENT TYPE, 2025-2035 (USD Billion)
7.2.4 BY SURGICAL APPROACH, 2025-2035 (USD Billion)
7.2.5 BY SURGICAL SCOPE, 2025-2035 (USD Billion)
7.3 US MARKET SIZE ESTIMATES; FORECAST
7.3.1 BY PROCEDURE TYPE, 2025-2035 (USD Billion)
7.3.2 BY MEDICAL CONDITION, 2025-2035 (USD Billion)
7.3.3 BY PATIENT TYPE, 2025-2035 (USD Billion)
7.3.4 BY SURGICAL APPROACH, 2025-2035 (USD Billion)
7.3.5 BY SURGICAL SCOPE, 2025-2035 (USD Billion)
7.4 Canada MARKET SIZE ESTIMATES; FORECAST
7.4.1 BY PROCEDURE TYPE, 2025-2035 (USD Billion)
7.4.2 BY MEDICAL CONDITION, 2025-2035 (USD Billion)
7.4.3 BY PATIENT TYPE, 2025-2035 (USD Billion)
7.4.4 BY SURGICAL APPROACH, 2025-2035 (USD Billion)
7.4.5 BY SURGICAL SCOPE, 2025-2035 (USD Billion)
7.5 Europe MARKET SIZE ESTIMATES; FORECAST
7.5.1 BY PROCEDURE TYPE, 2025-2035 (USD Billion)
7.5.2 BY MEDICAL CONDITION, 2025-2035 (USD Billion)
7.5.3 BY PATIENT TYPE, 2025-2035 (USD Billion)
7.5.4 BY SURGICAL APPROACH, 2025-2035 (USD Billion)
7.5.5 BY SURGICAL SCOPE, 2025-2035 (USD Billion)
7.6 Germany MARKET SIZE ESTIMATES; FORECAST
7.6.1 BY PROCEDURE TYPE, 2025-2035 (USD Billion)
7.6.2 BY MEDICAL CONDITION, 2025-2035 (USD Billion)
7.6.3 BY PATIENT TYPE, 2025-2035 (USD Billion)
7.6.4 BY SURGICAL APPROACH, 2025-2035 (USD Billion)
7.6.5 BY SURGICAL SCOPE, 2025-2035 (USD Billion)
7.7 UK MARKET SIZE ESTIMATES; FORECAST
7.7.1 BY PROCEDURE TYPE, 2025-2035 (USD Billion)
7.7.2 BY MEDICAL CONDITION, 2025-2035 (USD Billion)
7.7.3 BY PATIENT TYPE, 2025-2035 (USD Billion)
7.7.4 BY SURGICAL APPROACH, 2025-2035 (USD Billion)
7.7.5 BY SURGICAL SCOPE, 2025-2035 (USD Billion)
7.8 France MARKET SIZE ESTIMATES; FORECAST
7.8.1 BY PROCEDURE TYPE, 2025-2035 (USD Billion)
7.8.2 BY MEDICAL CONDITION, 2025-2035 (USD Billion)
7.8.3 BY PATIENT TYPE, 2025-2035 (USD Billion)
7.8.4 BY SURGICAL APPROACH, 2025-2035 (USD Billion)
7.8.5 BY SURGICAL SCOPE, 2025-2035 (USD Billion)
7.9 Russia MARKET SIZE ESTIMATES; FORECAST
7.9.1 BY PROCEDURE TYPE, 2025-2035 (USD Billion)
7.9.2 BY MEDICAL CONDITION, 2025-2035 (USD Billion)
7.9.3 BY PATIENT TYPE, 2025-2035 (USD Billion)
7.9.4 BY SURGICAL APPROACH, 2025-2035 (USD Billion)
7.9.5 BY SURGICAL SCOPE, 2025-2035 (USD Billion)
7.10 Italy MARKET SIZE ESTIMATES; FORECAST
7.10.1 BY PROCEDURE TYPE, 2025-2035 (USD Billion)
7.10.2 BY MEDICAL CONDITION, 2025-2035 (USD Billion)
7.10.3 BY PATIENT TYPE, 2025-2035 (USD Billion)
7.10.4 BY SURGICAL APPROACH, 2025-2035 (USD Billion)
7.10.5 BY SURGICAL SCOPE, 2025-2035 (USD Billion)
7.11 Spain MARKET SIZE ESTIMATES; FORECAST
7.11.1 BY PROCEDURE TYPE, 2025-2035 (USD Billion)
7.11.2 BY MEDICAL CONDITION, 2025-2035 (USD Billion)
7.11.3 BY PATIENT TYPE, 2025-2035 (USD Billion)
7.11.4 BY SURGICAL APPROACH, 2025-2035 (USD Billion)
7.11.5 BY SURGICAL SCOPE, 2025-2035 (USD Billion)
7.12 Rest of Europe MARKET SIZE ESTIMATES; FORECAST
7.12.1 BY PROCEDURE TYPE, 2025-2035 (USD Billion)
7.12.2 BY MEDICAL CONDITION, 2025-2035 (USD Billion)
7.12.3 BY PATIENT TYPE, 2025-2035 (USD Billion)
7.12.4 BY SURGICAL APPROACH, 2025-2035 (USD Billion)
7.12.5 BY SURGICAL SCOPE, 2025-2035 (USD Billion)
7.13 APAC MARKET SIZE ESTIMATES; FORECAST
7.13.1 BY PROCEDURE TYPE, 2025-2035 (USD Billion)
7.13.2 BY MEDICAL CONDITION, 2025-2035 (USD Billion)
7.13.3 BY PATIENT TYPE, 2025-2035 (USD Billion)
7.13.4 BY SURGICAL APPROACH, 2025-2035 (USD Billion)
7.13.5 BY SURGICAL SCOPE, 2025-2035 (USD Billion)
7.14 China MARKET SIZE ESTIMATES; FORECAST
7.14.1 BY PROCEDURE TYPE, 2025-2035 (USD Billion)
7.14.2 BY MEDICAL CONDITION, 2025-2035 (USD Billion)
7.14.3 BY PATIENT TYPE, 2025-2035 (USD Billion)
7.14.4 BY SURGICAL APPROACH, 2025-2035 (USD Billion)
7.14.5 BY SURGICAL SCOPE, 2025-2035 (USD Billion)
7.15 India MARKET SIZE ESTIMATES; FORECAST
7.15.1 BY PROCEDURE TYPE, 2025-2035 (USD Billion)
7.15.2 BY MEDICAL CONDITION, 2025-2035 (USD Billion)
7.15.3 BY PATIENT TYPE, 2025-2035 (USD Billion)
7.15.4 BY SURGICAL APPROACH, 2025-2035 (USD Billion)
7.15.5 BY SURGICAL SCOPE, 2025-2035 (USD Billion)
7.16 Japan MARKET SIZE ESTIMATES; FORECAST
7.16.1 BY PROCEDURE TYPE, 2025-2035 (USD Billion)
7.16.2 BY MEDICAL CONDITION, 2025-2035 (USD Billion)
7.16.3 BY PATIENT TYPE, 2025-2035 (USD Billion)
7.16.4 BY SURGICAL APPROACH, 2025-2035 (USD Billion)
7.16.5 BY SURGICAL SCOPE, 2025-2035 (USD Billion)
7.17 South Korea MARKET SIZE ESTIMATES; FORECAST
7.17.1 BY PROCEDURE TYPE, 2025-2035 (USD Billion)
7.17.2 BY MEDICAL CONDITION, 2025-2035 (USD Billion)
7.17.3 BY PATIENT TYPE, 2025-2035 (USD Billion)
7.17.4 BY SURGICAL APPROACH, 2025-2035 (USD Billion)
7.17.5 BY SURGICAL SCOPE, 2025-2035 (USD Billion)
7.18 Malaysia MARKET SIZE ESTIMATES; FORECAST
7.18.1 BY PROCEDURE TYPE, 2025-2035 (USD Billion)
7.18.2 BY MEDICAL CONDITION, 2025-2035 (USD Billion)
7.18.3 BY PATIENT TYPE, 2025-2035 (USD Billion)
7.18.4 BY SURGICAL APPROACH, 2025-2035 (USD Billion)
7.18.5 BY SURGICAL SCOPE, 2025-2035 (USD Billion)
7.19 Thailand MARKET SIZE ESTIMATES; FORECAST
7.19.1 BY PROCEDURE TYPE, 2025-2035 (USD Billion)
7.19.2 BY MEDICAL CONDITION, 2025-2035 (USD Billion)
7.19.3 BY PATIENT TYPE, 2025-2035 (USD Billion)
7.19.4 BY SURGICAL APPROACH, 2025-2035 (USD Billion)
7.19.5 BY SURGICAL SCOPE, 2025-2035 (USD Billion)
7.20 Indonesia MARKET SIZE ESTIMATES; FORECAST
7.20.1 BY PROCEDURE TYPE, 2025-2035 (USD Billion)
7.20.2 BY MEDICAL CONDITION, 2025-2035 (USD Billion)
7.20.3 BY PATIENT TYPE, 2025-2035 (USD Billion)
7.20.4 BY SURGICAL APPROACH, 2025-2035 (USD Billion)
7.20.5 BY SURGICAL SCOPE, 2025-2035 (USD Billion)
7.21 Rest of APAC MARKET SIZE ESTIMATES; FORECAST
7.21.1 BY PROCEDURE TYPE, 2025-2035 (USD Billion)
7.21.2 BY MEDICAL CONDITION, 2025-2035 (USD Billion)
7.21.3 BY PATIENT TYPE, 2025-2035 (USD Billion)
7.21.4 BY SURGICAL APPROACH, 2025-2035 (USD Billion)
7.21.5 BY SURGICAL SCOPE, 2025-2035 (USD Billion)
7.22 South America MARKET SIZE ESTIMATES; FORECAST
7.22.1 BY PROCEDURE TYPE, 2025-2035 (USD Billion)
7.22.2 BY MEDICAL CONDITION, 2025-2035 (USD Billion)
7.22.3 BY PATIENT TYPE, 2025-2035 (USD Billion)
7.22.4 BY SURGICAL APPROACH, 2025-2035 (USD Billion)
7.22.5 BY SURGICAL SCOPE, 2025-2035 (USD Billion)
7.23 Brazil MARKET SIZE ESTIMATES; FORECAST
7.23.1 BY PROCEDURE TYPE, 2025-2035 (USD Billion)
7.23.2 BY MEDICAL CONDITION, 2025-2035 (USD Billion)
7.23.3 BY PATIENT TYPE, 2025-2035 (USD Billion)
7.23.4 BY SURGICAL APPROACH, 2025-2035 (USD Billion)
7.23.5 BY SURGICAL SCOPE, 2025-2035 (USD Billion)
7.24 Mexico MARKET SIZE ESTIMATES; FORECAST
7.24.1 BY PROCEDURE TYPE, 2025-2035 (USD Billion)
7.24.2 BY MEDICAL CONDITION, 2025-2035 (USD Billion)
7.24.3 BY PATIENT TYPE, 2025-2035 (USD Billion)
7.24.4 BY SURGICAL APPROACH, 2025-2035 (USD Billion)
7.24.5 BY SURGICAL SCOPE, 2025-2035 (USD Billion)
7.25 Argentina MARKET SIZE ESTIMATES; FORECAST
7.25.1 BY PROCEDURE TYPE, 2025-2035 (USD Billion)
7.25.2 BY MEDICAL CONDITION, 2025-2035 (USD Billion)
7.25.3 BY PATIENT TYPE, 2025-2035 (USD Billion)
7.25.4 BY SURGICAL APPROACH, 2025-2035 (USD Billion)
7.25.5 BY SURGICAL SCOPE, 2025-2035 (USD Billion)
7.26 Rest of South America MARKET SIZE ESTIMATES; FORECAST
7.26.1 BY PROCEDURE TYPE, 2025-2035 (USD Billion)
7.26.2 BY MEDICAL CONDITION, 2025-2035 (USD Billion)
7.26.3 BY PATIENT TYPE, 2025-2035 (USD Billion)
7.26.4 BY SURGICAL APPROACH, 2025-2035 (USD Billion)
7.26.5 BY SURGICAL SCOPE, 2025-2035 (USD Billion)
7.27 MEA MARKET SIZE ESTIMATES; FORECAST
7.27.1 BY PROCEDURE TYPE, 2025-2035 (USD Billion)
7.27.2 BY MEDICAL CONDITION, 2025-2035 (USD Billion)
7.27.3 BY PATIENT TYPE, 2025-2035 (USD Billion)
7.27.4 BY SURGICAL APPROACH, 2025-2035 (USD Billion)
7.27.5 BY SURGICAL SCOPE, 2025-2035 (USD Billion)
7.28 GCC Countries MARKET SIZE ESTIMATES; FORECAST
7.28.1 BY PROCEDURE TYPE, 2025-2035 (USD Billion)
7.28.2 BY MEDICAL CONDITION, 2025-2035 (USD Billion)
7.28.3 BY PATIENT TYPE, 2025-2035 (USD Billion)
7.28.4 BY SURGICAL APPROACH, 2025-2035 (USD Billion)
7.28.5 BY SURGICAL SCOPE, 2025-2035 (USD Billion)
7.29 South Africa MARKET SIZE ESTIMATES; FORECAST
7.29.1 BY PROCEDURE TYPE, 2025-2035 (USD Billion)
7.29.2 BY MEDICAL CONDITION, 2025-2035 (USD Billion)
7.29.3 BY PATIENT TYPE, 2025-2035 (USD Billion)
7.29.4 BY SURGICAL APPROACH, 2025-2035 (USD Billion)
7.29.5 BY SURGICAL SCOPE, 2025-2035 (USD Billion)
7.30 Rest of MEA MARKET SIZE ESTIMATES; FORECAST
7.30.1 BY PROCEDURE TYPE, 2025-2035 (USD Billion)
7.30.2 BY MEDICAL CONDITION, 2025-2035 (USD Billion)
7.30.3 BY PATIENT TYPE, 2025-2035 (USD Billion)
7.30.4 BY SURGICAL APPROACH, 2025-2035 (USD Billion)
7.30.5 BY SURGICAL SCOPE, 2025-2035 (USD Billion)
7.31 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
7.31.1
7.32 ACQUISITION/PARTNERSHIP
7.32.1

Certified Researchers

Customize Report

Healthcare Market Segmentation

Healthcare By Procedure Type (USD Billion, 2025-2035)

Open Thoracic Surgery
Video-Assisted Thoracoscopic Surgery (VATS)
Robotics-Assisted Thoracic Surgery (RATS)

Healthcare By Medical Condition (USD Billion, 2025-2035)

Lung Cancer
Esophageal Cancer
Mediastinal Tumors
Pneumothorax
Empyema

Healthcare By Patient Type (USD Billion, 2025-2035)

Inpatients
Outpatients

Healthcare By Surgical Approach (USD Billion, 2025-2035)

Standard Approach
Minimally Invasive Approach

Healthcare By Surgical Scope (USD Billion, 2025-2035)

Diagnostic
Therapeutic
Emergency

Customer Stories

“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”

Noah Malgeri Co-Founder

“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”

Joseph Aguayo Sales Operations & Pricing Manager

“Thanks for sending the report it gives us a good global view of the Betaïne market.”

Peter Groot koerkamp Account and Business Manager

“Thank you, this will be very helpful for OQS.”

La Terria Dodd Program Support Specialist

“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”

Younghwan Choi Senior Retail Manager

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Mark Irwin Management Consultant

“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”

Rob Kooiker Group Product Manager HVAC & Fire Protection GMA

“We got the report in time, we really thank you for your support in this process. I also thank to all of your team as they did a great job.”

Akif Moroglu Strategy & Business Development Director

Case Study

Aerospace & Defense

Future of Dismounted Soldier Systems Market Trends & Adoption Roadmap 2019–2035

Features	License Type
Features	Single User	Multiuser License	Enterprise User
Price	$4,950	$5,950	$7,250
Maximum User Access Limit	1 User	Upto 10 Users	Unrestricted Access Throughout the Organization
Free Customization	✓	✓	✓
Direct Access to Analyst	✓	✓	✓
Deliverable Format	✓	✓	✓
Platform Access	✗	✗	✓
Discount on Next Purchase	10%	15%	15%
Printable Versions	✗	✗	✓